At the news
? BULLISHIMPACT 8/10 8-K filed Aug 5, 2026 at 06:32 ET
CVS Health reported strong Q2 2026 results with total revenues of $106.1 billion (+7.3% YoY) and Adjusted EPS of $2.58, significantly beating the $1.85 consensus. The company raised full-year 2026 guidance across all key metrics, driven by continued margin recovery in the Health Care Benefits segment and broad-based operational strength. This marks a second consecutive quarter of raised guidance, reinforcing the turnaround narrative.
- Q2 2026 total revenues of $106.1 billion, up 7.3% year-over-year
- Adjusted EPS of $2.58 vs consensus of $1.85 (beat by 39.4%)
- GAAP diluted EPS of $2.31 vs $0.80 in prior year
- Full-year 2026 GAAP EPS guidance raised to $6.84-$7.04 from $6.24-$6.44
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access